Genotipificación del melanoma.

Alicia Quiroga

doi:10.51643/22562915.345

Genotipying melanoma.

Genotipificación del melanoma.

Published 2013-10-01

How to Cite

1.

Quiroga A. Genotipying melanoma. Rev. colomb. hematol. oncol. [Internet]. 2013 Oct. 1 [cited 2025 Dec. 5];2(3):10-1. https://doi.org/10.51643/22562915.345

Download Citation

Citations

Citations in Crossref

Citations in Scopus

Google Sholar Citation

Issue

Vol. 2 No. 3 (2013): Octubre

Section

Editorial

How to Cite

1.

Quiroga A. Genotipying melanoma. Rev. colomb. hematol. oncol. [Internet]. 2013 Oct. 1 [cited 2025 Dec. 5];2(3):10-1. https://doi.org/10.51643/22562915.345

DOI

https://doi.org/10.51643/22562915.345

Dimensions

PlumX

license

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Alicia Quiroga

Instituto Nacional de Cancerología (INC)

Show authors biography

Alicia Quiroga,

Grupo Oncología Clínica, Instituto Nacional de Cancerología (INC), Bogotá, Colombia.

Article visits 146 | PDF visits

Downloads

Download data is not yet available.

Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417(6892):949-54.
Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 2003;95(24):1878-90.
Carranza H, Archila P, Vargas C, Bernal L, Otero JM, Rodríguez JK, et al. Genotipificación del melanoma en Colombia. Rev Colomb Hematol Oncol. 2013;2(3).
Menzies AM, Haydu LE, Visintin L, Carlino MS, Howle JR, Thompson JF, et al. Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma. Clin Cancer Res. 2012;18(12):3242-9.
Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, et al. High frequency of BRAF mutations in nevi. Nat Genet 2003;33(1):19-20.
Ascierto PA, Schadendorf D, Berking C, Agarwala SS, van Herpen CM, Queirolo P, et al. MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study. Lancet Oncol. 2013;14(3):249-56.
Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135-47.
Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006;24(26):4340-6.
Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 2010;330(6009):1410-3.